Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
196.25 USD | +1.75% |
|
+2.30% | +10.44% |
02-14 | Correction to AbbVie Names CEO Robert Michael Chairman Article | DJ |
02-14 | AbbVie: CEO to become Chairman of the Board | CF |
Capitalization | 340B 325B 307B 270B 483B 29,582B 536B 3,645B 1,351B 12,349B 1,276B 1,251B 51,654B | P/E ratio 2025 * |
26.3x | P/E ratio 2026 * | 21.7x |
---|---|---|---|---|---|
Enterprise value | 393B 376B 354B 311B 558B 34,140B 619B 4,206B 1,560B 14,252B 1,473B 1,443B 59,613B | EV / Sales 2025 * |
6.62x | EV / Sales 2026 * | 5.99x |
Free-Float |
96.39% | Yield 2025 * |
3.34% | Yield 2026 * | 3.49% |
Last Transcript: AbbVie Inc.
1 day | +1.75% | ||
1 week | +3.10% | ||
Current month | +6.72% | ||
1 month | +14.39% | ||
3 months | +18.95% | ||
6 months | +1.21% | ||
Current year | +10.44% |







Manager | Title | Age | Since |
---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 54 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 58 | 2022-06-22 |
Roopal Thakkar
CTO | Chief Tech/Sci/R&D Officer | - | 2002-12-31 |
Director | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CHM | Chairman | 71 | 2012-12-31 |
Roxanne Austin
BRD | Director/Board Member | 64 | 2012-12-31 |
William Burnside
BRD | Director/Board Member | 73 | 2012-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 6 M€ | 0.00% | - | |
6.85% | 33 M€ | +3.69% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+1.75% | +3.10% | +10.57% | +35.37% | 340B | ||
+1.53% | -1.34% | +9.61% | +255.73% | 760B | ||
-0.74% | +0.49% | -1.00% | -6.74% | 376B | ||
+3.09% | -4.61% | -31.01% | +74.47% | 355B | ||
+0.20% | +1.48% | +29.23% | -14.52% | 262B | ||
+0.63% | +0.60% | +16.78% | +32.18% | 229B | ||
+0.34% | -3.60% | -34.82% | +9.08% | 210B | ||
+0.45% | -0.79% | +8.74% | +20.24% | 210B | ||
+0.56% | -0.68% | +3.21% | +32.08% | 156B | ||
+0.12% | -1.20% | -7.46% | -47.73% | 145B | ||
Average | +0.67% | -1.47% | +0.38% | +39.02% | 304.45B | |
Weighted average by Cap. | +0.91% | -1.86% | +1.63% | +78.24% |
2025 * | 2026 * | |
---|---|---|
Net sales | 59.35B 56.73B 53.53B 47.04B 84.22B 5,157B 93.44B 635B 236B 2,153B 222B 218B 9,004B | 63.95B 61.13B 57.67B 50.69B 90.74B 5,556B 101B 685B 254B 2,319B 240B 235B 9,701B |
Net income | 11.88B 11.36B 10.72B 9.42B 16.86B 1,033B 18.71B 127B 47.17B 431B 44.54B 43.65B 1,803B | 14.84B 14.19B 13.38B 11.76B 21.06B 1,289B 23.36B 159B 58.91B 538B 55.62B 54.51B 2,251B |
Net Debt | 52.46B 50.14B 47.31B 41.58B 74.43B 4,558B 82.58B 562B 208B 1,903B 197B 193B 7,958B | 42.53B 40.66B 38.36B 33.71B 60.35B 3,696B 66.96B 455B 169B 1,543B 159B 156B 6,453B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-18 | 196.25 $ | +1.75% | 6,064,609 |
25-02-14 | 192.87 $ | -0.30% | 3,976,903 |
25-02-13 | 193.45 $ | +0.23% | 4,108,920 |
25-02-12 | 193.00 $ | +0.61% | 4,525,009 |
25-02-11 | 191.83 $ | +0.78% | 3,977,033 |
Delayed Quote Nyse, February 18, 2025 at 04:00 pm
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ABBV Stock

MarketScreener is also available in this country: United States.
Switch edition